AlzChem Group AG
ALZCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 12.7% | -1.2% | 4.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 32.2% | 70.9% | 63.5% | 68.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 22.3% | 20.8% | 19.4% | 21% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 11.9% | 11.1% | 10.1% | 10.9% |
| EPS Diluted | 1.89 | 1.57 | 1.44 | 1.49 |
| % Growth | 20.4% | 9% | -3.4% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | -$0 | $0 | $0 |
| Free Cash Flow | – | -$0 | $0 | $0 |